Showing results (1131-1140 of 1,398) with videos related to

Sort By:
Pageof 140
Drug Development Research|February 10, 2025
Assessment of Antidiarrheal Effect of Oleuropein Through µ-Oopioid Receptor Interaction Pathway: In Vivo and in Silico StudiesNishat Jahan, Manoj Mandal, Imam Hossen Rakib, et al.
Drug Development Research|August 13, 2024
Therapeutic effects of tilorone on mammary carcinogenesis through downregulation of pro-inflammatory cytokines and oxidative stressAbu Sufiyan Chhipa, Ayush Sharma, Srashti Verma, et al.
Drug Development Research|August 14, 2024
Nanovaccines: Immunogenic tumor antigens, targeted delivery, and combination therapy to enhance cancer immunotherapyZohreh Jahanafrooz, Fatemeh Oroojalian, Ahad Mokhtarzadeh, et al.
Drug Development Research|January 20, 2023
Two new alkaloids from Dendrobium nobile Lindl. exhibited neuroprotective activity, and dendrobine alleviated Aβ1-42 -induced apoptosis by inhibiting CDK5 activation in PC12 cellsCheng-Chen Zhang, Yan-Li Kong, Mao-Sheng Zhang, et al.
Drug Development Research|January 16, 2023
Discovery of 4-(4-aminophenyl)-6-phenylisoxazolo[3,4-b]pyridine-3-amine derivatives as novel FLT3 covalent inhibitors for the intervention of acute myeloid leukemiaQing-Xin Wang, Yi-Bo Wang, Jiu-Kai Sha, et al.
Drug Development Research|November 26, 2022
Discovery of pyrazole-carbohydrazide with indole moiety as tubulin polymerization inhibitors and anti-tumor candidatesRuo-Jun Man, Tian Lu, Chi-Chong Zheng, et al.
Drug Development Research|November 27, 2022
Expanding the therapeutic options for Candida infections using novel inhibitors of secreted aspartyl proteasesShuvechha Chakraborty, Kshitija Rahate, Chandan Kumar, et al.
Drug Development Research|December 26, 2022
Oridonin ameliorates acetaminophen-induced acute liver injury through ATF4/PGC-1α pathwayDongsheng Yu, Jiye Li, Yu Wang, et al.
Drug Development Research|December 3, 2022
Ulinastatin ameliorates the malignant progression of prostate cancer cells by blocking the RhoA/ROCK/NLRP3 pathwayZhiguang Liu, Xiaochun Zhu, Chenglin Xu, et al.
Drug Development Research|December 5, 2022
A new series of thiazole-hydrazone hybrids for Akt-targeted therapy of non-small cell lung cancerTurana Orujova, Abdulilah Ece, Gülşen Akalın Çiftçi, et al.
Pageof 140